← Back to Search

Probiotic for Lung Cancer

Q: Are there still openings in this experiment for volunteers?

<p>Indeed, based on the information from clinicaltrials.gov, this medical trial is currently accepting patients. It was first posted to the website on July 1st 2021 and most recently updated on May 3rd 2022. 40 people are being recruited for participation through one dedicated location.</p>

Q: What is the cap on the number of individuals enrolled in this medical trial?

<p>Affirmative. According to clinicaltrials.gov, this therapeutic experiment is presently seeking participants; it was first registered on 7/1/2021 and its most recent update was 5/3/2022. The trial aims to enrol 40 patients across a single site.</p>

Phase < 1

Waitlist Available

Led By Saranya Chumsri

Research Sponsored by Mayo Clinic

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 4 weeks

Awards & highlights

Study Summary

This trial will test whether probiotics can help the immune system better recognize and fight operable stage I-III breast or lung cancer.

Eligible Conditions

Lung Cancer
Breast Cancer

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 4 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 4 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 4 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Cytokine counts

Length and adherence of probiotics

Percentage of CD8+, CD4+, and T-reg cells

Trial Design

1Treatment groups

Experimental Treatment

Group I: Supportive care (biospecimen collection, probiotic)Experimental Treatment4 Interventions

Patients undergo collection of blood samples at baseline and time of surgery, and collection of stool samples at baseline and after completion of probiotic regimen. Patients receive probiotics PO once on day 1, and then BID or TID for 2-4 weeks before standard of care surgery. Patients also undergo collection of tissue samples during standard of care surgery.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Biopsy

2014

Completed Phase 4

~850

Therapeutic Conventional Surgery

2005

Completed Phase 3

~9850

Biospecimen Collection

2004

Completed Phase 2

~1730

Probiotic

2013

Completed Phase 4

~3570

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH

13,654 Previous Clinical Trials

40,933,147 Total Patients Enrolled

Mayo ClinicLead Sponsor

3,205 Previous Clinical Trials

3,766,778 Total Patients Enrolled

Saranya ChumsriPrincipal InvestigatorMayo Clinic

8 Previous Clinical Trials

1,408 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still openings in this experiment for volunteers?

"Indeed, based on the information from clinicaltrials.gov, this medical trial is currently accepting patients. It was first posted to the website on July 1st 2021 and most recently updated on May 3rd 2022. 40 people are being recruited for participation through one dedicated location."

Answered by AI

What is the cap on the number of individuals enrolled in this medical trial?

"Affirmative. According to clinicaltrials.gov, this therapeutic experiment is presently seeking participants; it was first registered on 7/1/2021 and its most recent update was 5/3/2022. The trial aims to enrol 40 patients across a single site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Effects of Probiotics on the Gut Microbiome and Immune System in Operable Stage I-III Breast or Lung Cancer

2021. "Effects of Probiotics on the Gut Microbiome and Immune System in Operable Stage I-III Breast or Lung Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04857697.